CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 320,000 shares (other)
- 4 Other disposition 10% owner disposed of 160,000 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at an average $48.50 ($727,573)
- 8-K Event Auditor change · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 24 of 34 · 672 filings